Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Welles Bernice R, Director. Director active across 2 companies, notably SPECTRUM PHARMACEUTICALS INC. Cumulatively, 1 disclosures have been published. Activity tracked since 17 June 2021. The latest transaction was filed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Bernice R. Welles serves as a Board Member at SPECTRUM PHARMACEUTICALS INC. She plays a key role in the governance of the company, providing her expertise to guide strategic decisions.